Natriumchlorid Kabipac (Sodium Chloride)

After infusion, sodium chloride dissociates into sodium and chloride ions, raising extracellular osmolarity. This draws water into the vascular space, expanding plasma volume, correcting sodium deficits, and helping maintain acid‑base balance and electrical neutrality.

The dose of Natriumchlorid Kabipac is determined by the prescribing clinician based on the patient’s clinical condition, electrolyte status, and volume needs. Specific dosing regimens are individualized and should follow local medical guidelines.

Safety data for Natriumchlorid Kabipac in pregnancy and lactation are limited. Use is generally considered only when the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made by the treating physician.

To order Natriumchlorid Kabipac, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Natriumchlorid Kabipac is an isotonic sodium chloride injection comparable to standard 0.9% saline. Its composition and clinical effects are similar, but product specifications, regulatory status, and supply chain logistics may differ, making it a suitable alternative for institutions seeking EU‑compliant sources.

Store Natriumchlorid Kabipac at ambient temperature, preferably below 25 °C. Keep the vials in their original packaging, protect them from direct light, moisture, and extreme temperature fluctuations to maintain product integrity.

Natriumchlorid Kabipac is administered intravenously. The solution is typically infused through a peripheral or central line, following the infusion rate recommended by the prescriber and adjusted according to the patient’s fluid status and clinical response.

Serious risks include severe hypernatremia, which can cause neurologic symptoms, pulmonary edema from fluid overload, and rare allergic reactions such as anaphylaxis. Continuous monitoring of electrolytes and fluid balance helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride solutions, those with uncontrolled heart failure or severe renal impairment where fluid overload is a concern, and individuals for whom alternative fluid management strategies are clinically preferred should avoid using Natriumchlorid Kabipac.